Company Filing History:
1 out of 30 
1 out of 20 Years Active: 2024
Title: Renlin Wang: Innovator in BCR-ABL Inhibitors
Introduction
Renlin Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BCR-ABL inhibitors. His work is crucial for advancing treatments for cancer and other diseases.
Latest Patents
Renlin Wang holds a patent for "Tricyclic compounds as BCR-ABL inhibitors." This patent includes compounds represented by a specific formula, which are designed to inhibit the BCR-ABL protein. These compounds are essential in the fight against cancer, providing new avenues for treatment.
Career Highlights
Throughout his career, Renlin Wang has worked with Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Limited. His experience in these companies has allowed him to focus on innovative solutions in the pharmaceutical industry.
Collaborations
Renlin Wang has collaborated with notable colleagues such as Yunlong Zhou and Guozhi Tang. Their combined expertise has contributed to the advancement of research in the field of cancer treatment.
Conclusion
Renlin Wang's contributions to the development of BCR-ABL inhibitors highlight his importance as an inventor in the pharmaceutical industry. His work continues to pave the way for innovative treatments that can improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.